Paraguay vs Poland: HIV/AIDS deaths averted by antiretroviral therapy
Paraguay
748.25 deaths
in 2024
Poland
683 deaths
in 2021
Paraguay rank
82nd
Poland rank
84th
HIV/AIDS deaths averted by antiretroviral therapy over time
- Paraguay
- Poland
How they compare
Paraguay currently reports 748.25 deaths against 683 deaths in Poland, a difference of 65.25 deaths.
That makes Paraguay's figure about 1.1 times Poland's.
The two have swapped places 2 times across 32 shared years of data; in 1990 it was Poland ahead.
Paraguay ranks 82nd and Poland ranks 84th of 157 countries.
Poland has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Paraguay | Poland | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 40.1 deaths | 40.1 deaths | Poland |
| 2000s | 104.86 deaths | 326.9 deaths | 222.04 deaths | Poland |
| 2010s | 475.81 deaths | 512.7 deaths | 36.89 deaths | Poland |
| 2020s | 639.75 deaths | 662 deaths | 22.25 deaths | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Paraguay or Poland?
- Paraguay, at 748.25 deaths against 683 deaths in Poland as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Paraguay and Poland?
- 65.25 deaths, with Paraguay ahead.
- How many years of comparable data are there for Paraguay and Poland?
- 32 years are reported by both, from 1990 to 2021.
- How do Paraguay and Poland rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Paraguay ranks 82nd and Poland ranks 84th of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.